How Container Closure Integrity Testing (CCIT) Technologies Help CDMOs Fulfill Commitment To Quality

By Oliver Stauffer

When selecting a contract development and manufacturing organization (CDMO), prospective clients prioritize quality assurance, as rigorous quality control procedures play a major role in safeguarding a product on its journey to the patient. Packaging is critical in maintaining drug quality because it serves as protection for both the product itself and the manufacturer's commitment to patient safety throughout the product life cycle. Lacking knowledge of container closure integrity testing (CCIT) can put a CDMO at a disadvantage when compared to competitors who have embraced advanced CCIT solutions. Consequently, it is imperative for CDMOs to possess a comprehensive understanding of CCIT.